 |
| Research article summary (published 6 Dec 2009): |
|
Free Full Text! See links below |
High serum Abeta and vascular risk factors in first-degree relatives of Alzheimer's disease patients.
Full Abstract
The main objective of this study was to determine whether elevated blood beta-amyloid (Abeta) levels among the first-degree relatives of patients with Alzheimer's Disease (AD) are associated with vascular risk factors of AD. Serum Abeta was measured in samples from 197 cognitively normal first-degree relatives of patients with AD-like dementia. Study participants were recruited as part of an ancillary study of the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT subpopulation). The ADAPT subpopulation was found to be similar in age, sex, and ethnicity to another cognitively normal cohort (n = 98). Using cross-sectional analyses, we examined the association of Abeta with blood pressure, lipid levels, apolipoprotein E genotypes, and the use of prescribed medication to treat vascular risk factors in the ADAPT subpopulation. Abeta(1-40) was positively associated with age, use of antihypertensives, and serum creatinine, and we observed a marginal negative interaction on Abeta(1-40) associated with systolic blood pressure and use of antihypertensives. Serum Abeta(1-42) was associated with statin use and a positive correlation of Abeta (1-42) with HDL was observed among statin nonusers. These findings suggest that high Abeta in the periphery among the family history-enriched cohorts may be due to enrichment of vascular risk factors and may reflect presymptomatic AD pathology. It remains to be determined whether the association of Abeta with medications used for treating vascular risk factors indicates prevention of AD. Longitudinal evaluation of blood Abeta in this cohort will provide a better understanding of the significance of this association in AD etiology.
Author information
Author/s: Abdullah, Laila (L); Luis, Cheryl (C); Paris, Daniel (D); Ait-ghezala, Ghania (G); Mouzon, Benoit (B); Allen, Elizabeth (E); Parrish, Julia (J); Mullan, Myles A (MA); Ferguson, Scott (S); Wood, Marcie (M); Crawford, Fiona (F); Mullan, Michael (M);
Affiliation: Roskamp Institute, Sarasota, Florida 34243, USA. labdullah(-atsign-)rfdn.org
Grants: 7U01AG15477-02 (Agency:NIA NIH HHS)
Journal and publication information
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
Journal: Molecular medicine (Cambridge, Mass.) (Mol Med), published in United States. (Language: eng)
Reference: -2009 Mar-Apr; vol 15 (issue 3-4) : pp 95-100
Dates: Created 2009/03/05; Completed 2009/04/17;
PMID: 19081767, status: MEDLINE (last retrieval date: 4/17/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
This article has not been indexed for related articles as yet, however you can still use the live related article search links below.
See a large map of 100+ related articles.